InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Wesche Holger, Directeur Scientifique. Director active across 1 company, notably Harpoon Therapeutics, Inc.. In total, 1 filings have been published. Activity tracked since 1 July 2021. The latest transaction was disclosed on 1 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wesche Holger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
10,000 shares@ US$0.60100.0% of flowCommon StockSEC:0001209191-21-045618:0
1 of 1 declaration
About Wesche Holger
Wesche Holger serves as Chief Scientific Officer at Harpoon Therapeutics, Inc. He is responsible for leading research and developing new treatments. Holger plays a key role in scientific innovation and implementing research strategies. His expertise in biotechnology is essential for the success of Harpoon Therapeutics.
